Clinical, histopathological, and molecular analyses of IDH-wild-type WHO grade II–III gliomas to establish genetic predictors of poor prognosis-Reference-Cited by-同舟云学术

Clinical, histopathological, and molecular analyses of IDH-wild-type WHO grade II–III gliomas to establish genetic predictors of poor prognosis

Published:2019-07-19 Issue:4 Volume:36 Page:135-143
ISSN:1433-7398
Container-title:Brain Tumor Pathology
language:en
Short-container-title:Brain Tumor Pathol

Author:

Kuwahara Kiyonori,Ohba Shigeo^ORCID,Nakae Shunsuke,Hattori Natsuki,Pareira Eriel Sandika,Yamada Seiji,Sasaki Hikaru,Abe Masato,Hasegawa Mitsuhiro,Hirose Yuichi

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Neurology (clinical),Oncology,General Medicine

Link

http://link.springer.com/content/pdf/10.1007/s10014-019-00348-9.pdf

Reference30 articles.

1. Louis DN, Ohgaki H, Wiestler OD et al (2016) WHO classification of tumours of the central nervous system, 4th edn. IARC, Lyon

2. Wijnenga MMJ, Dubbink HJ, French PJ et al (2017) Molecular and clinical heterogeneity of adult diffuse low-grade IDH wild-type gliomas: assessment of TERT promoter mutation and chromosome 7 and 10 copy number status allows superior prognostic stratification. Acta Neuropathol 134:957–959

3. Aibaidula A, Chan AKY, Shi Z et al (2017) Adult IDH wild-type lower grade gliomas should be further stratified. Neuro Oncol 19(10):1327–1337

4. Weller M, Weber RG, Willscher E et al (2015) Molecular classification of diffuse cerebral WHO grade II/III gliomas using genome- and transcriptome-wide profiling improves stratification of prognostically distinct patient groups. Acta Neuropathol 129:679–693

5. Stichel D, Ebrahimi A, Reuss D et al (2018) Distribution of EGFR amplification, combined chromosome 7 gain and chromosome 10 loss, and TERT promoter mutation in brain tumors and their potential for the reclassification of IDHwt astrocytoma to glioblastoma. Acta Neuropathol 136(5):793–803

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Optimizing the risk stratification of astrocytic tumors by applying the cIMPACT-NOW Update 3 signature: real-word single center experience;Scientific Reports;2023-11-16

2. Impact of the data augmentation on the detection of brain tumor from MRI images based on CNN and pretrained models;Multimedia Tools and Applications;2023-10-02

3. IDH wild-type lower-grade gliomas with glioblastoma molecular features: a systematic review and meta-analysis;Brain Tumor Pathology;2023-05-22

4. Association of human telomerase reverse transcriptase promoter mutation with unfavorable prognosis in glioma: A systematic review and meta-analysis;Journal of Research in Medical Sciences;2023

5. Optimizing the risk stratification of astrocytic tumors by applying the cIMPACT- NOW Update 3 signature: real-word single center experience;2022-12-28